System and method for photon density wave pulse oximetry and pulse hemometry

1. A monitoring system, comprising:

an emitter configured to emit light into tissue;

a modulator configured to modulate the light to generate photon density waves at a modulation frequency, wherein the modulation frequency is above about 50 MHz and below about 3 GHz;

a detector configured to detect relative characteristics of the photon density waves including amplitude changes and phase shifts;

a processor configured to make determinations relating to a value of a physiologic parameter of the tissue based on the phase shifts, and the processor is configured to reject or accept the determined value of the physiologic parameter based on whether calculations based on the relative characteristics are complimentary; and

a display feature configured to present the value of the physiologic parameter to a user.

2. The system of claim 1 , wherein the modulator is configured to modulate the light at the modulation frequency above approximately 100 MHz and below approximately 1 GHz.

3. The system of claim 1 , wherein the processor is configured to calculate an estimated number of scattering particles in the tissue based on detected phase shifts.

4. The system of claim 1 , comprising a plurality of emitters, wherein the modulator is configured to modulate light from the plurality of emitters to sweep the tissue with a plurality of modulation frequencies.

5. The system of claim 1 , wherein the modulator comprises a DVD R/W driver circuit.

6. The system of claim 1 , comprising a plurality of emitters capable of establishing a phased array and a second calculation component configured to utilize the phased array to identify a region of the tissue rich with pulsatile signals or a region of the tissue with low saturation.

7. The system of claim 1 , comprising a noise detection feature configured to identify noise artifacts based on a defined range of calculated values based on the amplitude changes and phase shifts.

8. The system of claim 1 , wherein the modulator is configured to establish a phased array of photon density waves for use in pulse oximetry and hemometry techniques.

9. A method, comprising:

modulating light at a modulation frequency that is within a range between 100 MHz and 3 GHz to generate photon density waves in a medium;

detecting relative amplitude changes and phase shifts in the photon density waves;

calculating a value related to a number of scattering particles in the medium based on the phase shifts; and

detecting and graphically indicating a physiologic value related to the scattering particles in the medium based on the phase shifts.

10. The method of claim 9 , comprising modulating multiple light emissions to generate a phased array of photon density waves.

11. The method of claim 10 , comprising identifying regions rich with pulsatile signals based on the phased array of photon density waves.

12. The method of claim 9 , comprising identifying regions of low saturation based on the phased array of photon density waves.

13. The method of claim 9 , comprising sweeping the modulation frequency through a range from 500 MHz to 1 GHz.

14. A method, comprising:

emitting light from a plurality of light sources into a medium;

modulating the light from the plurality of light sources at different frequencies to generate photon density waves, wherein the different frequencies are approximately 100 MHz to 1 GHz;

coordinating the modulation of the plurality of light sources to establish coordinated wave characteristics;

identifying noise based on whether the coordinated wave characteristics are within a defined physiologic regime; and

calculating values for physiologic features of the medium based on detection of relative characteristics of the photon density waves after passing through the medium.

15. The method of claim 14 , wherein the coordinated wave characteristics comprise focused wave intensity in a specified region of the medium.

16. The method of claim 14 , comprising sweeping the medium with a plurality of modulation frequencies to facilitate calibration.

17. Application instructions stored on a tangible, non-transitory computer-readable medium, the application instructions comprising:

code configured to control modulation of light at a modulation frequency to generate photon density waves in a medium, wherein the modulation frequency is above about 100 MHz and below about 3 GHz;

code configured to facilitate detection of relative amplitude changes and phase shifts in the photon density waves;

code configured to calculate a value related to a number of scattering particles in the medium based on the phase shifts; and

code configured to identify and graphically indicate a physiologic value related to the scattering particles in the medium based on the phase shifts.

18. The application instructions of claim 17 , comprising code configured to control modulation of multiple light emissions to generate a phased array of photon density waves.

19. A monitoring system, comprising:

an emitter configured to emit light into tissue;

a modulator configured to modulate the light to generate photon density waves at a modulation frequency, wherein the modulation frequency is above about 50 MHz and below about 3 GHz;

a detector configured to detect relative characteristics of the photon density waves including amplitude changes and phase shifts;

a processor configured to make determinations relating to a value of a physiologic parameter of the tissue based on the phase shifts, and the processor is configured to calculate an estimated number of scattering particles in the tissue based on detected phase shifts; and

a display feature configured to present the value of the physiologic parameter to a user.

20. A monitoring system, comprising:

an emitter configured to emit light into tissue;

a modulator configured to modulate the light to generate photon density waves at a modulation frequency, wherein the modulation frequency is above about 50 MHz and below about 3 GHz;

a detector configured to detect relative characteristics of the photon density waves including amplitude changes and phase shifts;

a noise detection feature configured to identify noise artifacts based on a defined range of calculated values based on the amplitude changes and phase shifts;

a processor configured to make determinations relating to a value of a physiologic parameter of the tissue based on the phase shifts; and

a display feature configured to present the value of the physiologic parameter to a user.